TY  - GEN
AU  - Solal-Celigny,Philippe
TI  - Rituximab by subcutaneous route
SN  - 1747-4094
PY  - 2015///1112
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Lymphoma, Follicular
KW  - drug therapy
KW  - Rituximab
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1586/17474086.2015.1024651
ER  -